主页实验库实验详情

E-GEOD-62626 GSE62626 transcription profiling by array, compa… Homo sapiens, Mus musculus

Combined MYC and TP53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

·发布 April 23, 2015 ·更新 April 27, 2015

样本数

实验数

芯片平台

相关文献

实验描述

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

参考文献

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.

Hill RM, Kuijper S, Lindsey JC, Petrie K, Schwalbe EC, Barker K, Boult JK, Williamson D, Ahmad Z, Hallsworth A, Ryan SL, Poon E, Robinson SP, Ruddle R, Raynaud FI, Howell L, Kwok C, Joshi A, Nicholson SL, Crosier S, Ellison DW, Wharton SB, Robson K, Michalski A, Hargrave D, Jacques TS, Pizer B, Bailey S, Swartling FJ, Weiss WA, Chesler L, Clifford SC

PMID: 25533335

芯片平台

A-MEXP-1174

Illumina MouseRef-8 v2.0 Expression BeadChip（48 例）

A-GEOD-13534

Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)（40 例）

样本属性

age class at diagnosis infant < 4 yrs

infant, Non-infant

model

MYC, MYCN

organism

Homo sapiens, Mus musculus

organism part

cells, medulloblastoma tumor, primary

p53

KI_het, KI_hom, mut, WT

pathology

CLA, DN, LCA, MBNOS

sex

female, male

subgroup

G3, G4, SHH, WNT

实验信息

登记号

E-GEOD-62626

GEO 编号

GSE62626

实验类型

transcription profiling by array, comparative genomic hybridization by array

物种

Homo sapiens, Mus musculus

发布日期

April 23, 2015

更新日期

April 27, 2015

提交者

Ed Schwalbe

外部链接

ArrayExpress 原始页 NCBI GEO：GSE62626

分析服务

Combined MYC and TP53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

联系地址

微信公众号